The robots are capable of swimming through a patient’s vascular system and removing blood clots. “It’s unbelievable," one Stanford researcher said. "This is a sea-change technology that will drastically improve our ability to help people.”

California-based Reflow Medical gained the approval after submitting data from the DEEPER REVEAL clinical trial. The device was associated with a high success rate and improved outcomes in CLTI patients.

The dual-layer micromesh stent was designed with the flexibility of an open-cell stent and is available in multiple sizes.

Researchers tracked the rates of major gastrointestinal bleeding in patients with AFib randomized to receive edoxaban or a vitamin K antagonist after a successful TAVR procedure.

"As cannabis legalization increases, it is crucial to understand the public health and clinical implications of marijuana use," researchers wrote in JAMA Cardiology.

Gregg Fonarow, MD, discussed the American Heart Association's stroke guidelines, the growing influence of AI and much more.

Some patients struggle to bounce back after being hospitalized, but too much sedentary behavior could cause their health to get even worse. The research teams behind two separate studies are highlighting the importance of staying active.

Researchers have used a state-of-the-art microscope and advanced AI to track clotting risks in CAD patients. The goal is to spot blood clots before they even happen, ensuring patients are prescribed the right therapy for their specific needs.